ArticleMolecular cancer2022

A PIK3CA-mutant breast cancer metastatic patient-derived organoid approach to evaluate alpelisib treatment for multiple secondary lesions.

Sara Donzelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.